BiondVax
BVXV
$1.36
Share price
0.74%
Change (1 day)
-37.33%
Change (1 year)
Categories
BiondVax (BVXV) - P/B ratio
P/B ratio as of April 2024 : -0.6983
According to BiondVax's latest financial reports the company has a price-to-book ratio of -0.6983.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
BiondVax - P/B ratio (from 2015 to 2022)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2022-12-31 | 2.12 | -63.21% |
| 2021-12-31 | 5.78 | -181.01% |
| 2020-12-31 | -7.13 | 43.49% |
| 2019-12-31 | -4.97 | 32.25% |
| 2018-12-31 | -3.76 | -275.4% |
| 2017-12-31 | 2.14 | 27.64% |
| 2016-12-31 | 1.68 | 8.05% |
| 2015-12-31 | 1.55 | |
| 2014-12-31 | N/A | |
| 2013-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.43 | -447.66% | 🇺🇸 USA |